missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Novus Biologicals™ GITR/TNFRSF18 Antibody (Korea Natl.Cancer Ctr. patent anti-GITR) - Humanized, Novus Biologicals™
Human Monoclonal Antibody
Brand: Novus Biologicals™ NBP3-28151-100ug
This item is not returnable.
View return policy
Description
GITR/TNFRSF18 Monoclonal antibody specifically detects GITR/TNFRSF18 in Human samples. It is validated for Flow Cytometry,ELISA,Functional Assay
Specifications
| GITR/TNFRSF18 | |
| Monoclonal | |
| Unconjugated | |
| Q9Y5U5 | |
| Human | |
| Protein A purified | |
| RUO | |
| Primary | |
| Reconstitute with sterile, distilled water to a final concentration of 1 mg/mL. Gently shake to solubilize completely. Do not vortex. | |
| Store at -20°C in powder form. Store at -80°C once reconstituted. | |
| IgG1 |
| Flow Cytometry, ELISA, Functional Assay | |
| Korea Natl.Cancer Ctr. patent anti-GITR | |
| Lyophilized from 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2) | |
| Activation-inducible TNFR family receptor, AITRTNF receptor superfamily activation-inducible protein, CD357 antigen, GITR-D, GITRtumor necrosis factor receptor superfamily member 18, Glucocorticoid-induced TNFR-related protein, tumor necrosis factor receptor superfamily, member 18 | |
| TNFRSF18/ GITR/ CD357 | |
| 100 μg | |
| Apoptosis | |
| 8784 | |
| Human | |
| Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction